Skip to content
Screener

Globus Medical GMED Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Boston Scientific logo
Boston ScientificBSX
——

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$11.01B+53.9%
Enterprise value$10.61B+50.6%
P/E20.6×+0.5×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0×0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Balance at June 30,2026Level 1Level 2Level 3
Cash equivalents$377,042$377,042——
Municipal bonds13,256—13,256—
Corporate debt securities103,539—103,539—
Commercial paper63,901—63,901—
Asset-backed securities103,788—103,788—
Government, federal agency, and other sovereign obligations48,27144,1434,128—
Liabilities:
Business acquisition liabilities105,389——105,389

Item 1. Financial Statements

FAQ

What is Globus Medical's business combination, contingent consideration, liability?
Globus Medical (GMED) reported business combination, contingent consideration, liability of $105.39M in Q2 2026.
How has Globus Medical's business combination, contingent consideration, liability changed year-over-year?
Globus Medical's business combination, contingent consideration, liability increased by 0.4% year-over-year, from $104.97M to $105.39M.
What is the long-term trend for Globus Medical's business combination, contingent consideration, liability?
Over 5 years (2020 to 2025), Globus Medical's business combination, contingent consideration, liability has grown at a 22.2% compound annual growth rate (CAGR), from $37.27M to $101.51M.
What does business combination, contingent consideration, liability mean?
Business Combination, Contingent Consideration, Liability

Ask your AI about Globus Medical's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude